PubMed

alpha-Tocopherol supplementation decreases plasminogen activator inhibitor-1 and P-selectin levels in type 2 diabetic patients.

Devaraj S, Chan AV Jr, Jialal I.

Diabetes Care. 2002 Mar;25(3):524-9.PMID: 11874941 [PubMed - indexed for MEDLINE]Related articlesFree article

Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients.

Devaraj S, Jialal I.

Free Radic Biol Med. 2000 Oct 15;29(8):790-2.PMID: 11053781 [PubMed - indexed for MEDLINE]Related articles

Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes.

Jokl R, Klein RL, Lopes-Virella MF, Colwell JA.

Diabetes Care. 1995 Aug;18(8):1150-5.PMID: 7587850 [PubMed - indexed for MEDLINE]Related articles

A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients.

Vignini A, Nanetti L, Moroni C, Testa R, Sirolla C, Marra M, Manfrini S, Fumelli D, Marcheselli F, Mazzanti L, Rabini RA.

Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):15-22. Epub 2007 Oct 18.PMID: 17949955 [PubMed - indexed for MEDLINE]Related articles

Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation.

Devaraj S, Jialal I.

Circulation. 2000 Jul 11;102(2):191-6.PMID: 10889130 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.

Tan KT, Tayebjee MH, Lim HS, Lip GY.

Diabet Med. 2005 Dec;22(12):1657-62.PMID: 16401308 [PubMed - indexed for MEDLINE]Related articles

Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients.

Testa R, Bonfigli AR, Sirolla C, Boemi M, Manfrini S, Mari D, Testa I, Sacchi E, Franceschi C.

Diabetes Nutr Metab. 2004 Aug;17(4):217-21.PMID: 15575342 [PubMed - indexed for MEDLINE]Related articles

Effect of troglitazone on serum gamma-glutamyltransferase activity and plasma t-PA/PAI-1 complex in type 2 diabetic patients.

Koh H, Akiyama Y, Yui K.

Arzneimittelforschung. 2006;56(4):288-94.PMID: 16724515 [PubMed - indexed for MEDLINE]Related articles

Platelet plasminogen activator inhibitor 1 in patients with type II diabetes.

Jokl R, Laimins M, Klein RL, Lyons TJ, Lopes-Virella MF, Colwell JA.

Diabetes Care. 1994 Aug;17(8):818-23.PMID: 7956624 [PubMed - indexed for MEDLINE]Related articles

Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patients.

Bonfigli AR, Pieri C, Manfrini S, Testa I, Sirolla C, Ricciotti R, Marra M, Compagnucci P, Testa R.

Diabetes Nutr Metab. 2001 Apr;14(2):71-7.PMID: 11383676 [PubMed - indexed for MEDLINE]Related articles

Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.

Mansfield MW, Catto AJ, Carter AM, Grant PJ.

Diabet Med. 1998 Nov;15(11):953-7.PMID: 9827850 [PubMed - indexed for MEDLINE]Related articles

Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C.

Antoniades C, Tousoulis D, Tountas C, Tentolouris C, Toutouza M, Vasiliadou C, Tsioufis C, Toutouzas P, Stefanadis C.

Diabet Med. 2004 Jun;21(6):552-8.PMID: 15154938 [PubMed - indexed for MEDLINE]Related articles

C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 gene.

Testa R, Bonfigli AR, Sirolla C, Marra M, Boemi M, Mari D, Sacchi E, Dolci A, Catalano A, Procopio A, Ceriello A.

Nutr Metab Cardiovasc Dis. 2008 Mar;18(3):220-6. Epub 2007 Apr 12.PMID: 17433639 [PubMed - indexed for MEDLINE]Related articles

Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.

Aso Y, Matsumoto S, Fujiwara Y, Tayama K, Inukai T, Takemura Y.

Metabolism. 2002 Apr;51(4):471-6.PMID: 11912556 [PubMed - indexed for MEDLINE]Related articles

A strong inverse relationship between PAI-1 and Lp(a) in hypertensive Type 2 diabetic patients.

Testa R, Bonfigli AR, Sirolla C, Pieri C, Marra M, Antonicelli R, Manfrini S, Compagnucci P, Testa I.

Diabetes Nutr Metab. 1999 Dec;12(6):400-6.PMID: 10782561 [PubMed - indexed for MEDLINE]Related articles

Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity.

Umpaichitra V, Hussain MM, Castells S.

Pediatr Res. 2005 Sep;58(3):483-7. Epub 2005 May 18. Erratum in: Pediatr Res. 2006 May;59(5):746. PMID: 15901895 [PubMed - indexed for MEDLINE]Related articles

Vitamin C affects thrombosis/ fibrinolysis system and reactive hyperemia in patients with type 2 diabetes and coronary artery disease.

Tousoulis D, Antoniades C, Tountas C, Bosinakou E, Kotsopoulou M, Toutouzas P, Stefanadis C.

Diabetes Care. 2003 Oct;26(10):2749-53.PMID: 14514574 [PubMed - indexed for MEDLINE]Related articlesFree article

Peripheral artery disease in type 2 diabetes: the role of fibrinolysis.

Lapolla A, Piarulli F, Sartore G, Rossetti C, Martano L, Carraro P, De Paoli M, Fedele D.

Thromb Haemost. 2003 Jan;89(1):91-6.PMID: 12540958 [PubMed - indexed for MEDLINE]Related articles

Increased soluble E-selectin levels in type 2 diabetic patients with peripheral arterial disease.

Boulbou MS, Koukoulis GN, Vasiou KG, Petinaki EA, Gourgoulianis KI, Fezoulidis IB.

Int Angiol. 2004 Mar;23(1):18-24.PMID: 15156125 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.

Yu Y, Suo L, Yu H, Wang C, Tang H.

Diabetes Res Clin Pract. 2004 Aug;65(2):95-104.PMID: 15223221 [PubMed - indexed for MEDLINE]Related articles